{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-040728","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2026-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.772125+00:00","generated_at":"2026-05-15T07:03:23.713323+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bluejay Diagnostics completes 624 of 750 patient enrollments in SYMON-II sepsis trial","bullets":["SYMON-II pivotal trial for Symphony IL-6 sepsis triage test enrolled 624 of 750 target patients.","Enrollment completion expected within 2-3 months, subject to site activity and patient flow.","Inclusion and exclusion criteria have not caused significant patient exclusions, per CEO Neil Dey."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-040728","json":"https://secwatch.observer/filing/0001213900-26-040728.json","markdown":"https://secwatch.observer/filing/0001213900-26-040728.md","text":"https://secwatch.observer/filing/0001213900-26-040728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026040728/0001213900-26-040728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026040728/ea0285343-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:03:23.713323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}